AstraZeneca is a global biotechnology and pharmaceutical company headquartered in the UK with over 80,000 employees stationed in over 100 countries. Founded in Sweden under the name Astra AB, the company had witnessed significant growth since the merger with Zeneca in 1999 and became AstraZeneca (AZ) as it is known today. From 2005 to 2007, AZ acquired KuDOS, CAT, Arrow, and MedImmune and expanded its pharmaceutical products to include anticancer agents, antibiotics, antiviral therapies, and more. AZ strives to transform the future of healthcare through the advancement of research and development in oncology, rare diseases and other areas, leading to innovative medical discoveries. AZ is aiming to lead a revolution in oncology to redefine cancer care, focusing on clinical strategies, medicines, and patient experience. AZ and partners have released over 3.1 billion doses of its COVID-19 vaccine in over 180 countries, while making it accessible to low and middle income countries.. The company’s mission is to improve access to medication in healthcare systems and societies with a focus on the patients healthcare experiences and be conscious of sustainability issues.
We are honored to have AZ as a Gold sponsor who will be attending our 2024 AIChE Mid-Atlantic Regional Conference at UMBC and the company’s representatives will be at the Career Fair to clarify any questions that our conference attendees may have. AZ is also holding a workshop on Saturday from 2 to 3 PM, titled “Engineering for Patient Impact” with a panel of four chemical engineers in different positions, where they will discuss the life cycle of a drug and the diverse career opportunities with the company. Notably, Mr. Pran Patel, the Vice President of Global Operations, is one of our Keynote speakers during our opening ceremony. We thank you for your tremendous support of our conference effort, and we look forward to hosting you this April!